To understand the prognostic clinical value of miR-21, PDCD4 and MSH2 expression in GBM patient survival, we performed Multivariate survival analysis on 197 GBM patients, using a in house Glioblastoma Bio Discovery Portal (GBM-BioDP) [29]. The gene discussed is PDCD4; the disease is glioblastoma.